Zobrazeno 1 - 10
of 53
pro vyhledávání: '"FDA approvals"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 2, p 243 (2024)
A total of nine TIDES (pepTIDES and oligonucleoTIDES) were approved by the FDA during 2023. The four approved oligonucleotides are indicated for various types of disorders, including amyotrophic lateral sclerosis, geographic atrophy, primary hyperoxa
Externí odkaz:
https://doaj.org/article/4dae35486161477388f8e34c1bc7a62d
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5405-5414 (2021)
Abstract Background It has been suggested that the results from fragile trials are less likely to translate into benefit in routine clinical practice. Methods We searched the Food and Drug Administration (FDA) archives to identify drug approvals for
Externí odkaz:
https://doaj.org/article/2af1bdd1e81e43c287847d8356afe589
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Urothelial carcinoma therapy is a rapidly evolving and expanding field. Traditional cytotoxic chemotherapy regimens have not produced optimal long-term outcomes, and many urothelial cancer patients have comorbidities that disqualify them as chemother
Externí odkaz:
https://doaj.org/article/87ca4316cf5a46d38baf68045365ce0b
Autor:
Alexander C. Martins, Mariana Y. Oshiro, Fernando Albericio, Beatriz G. de la Torre, Gustavo José V. Pereira, Rodrigo V. Gonzaga
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2325 (2022)
Despite belonging to a relatively new class of pharmaceuticals, biological drugs have been used since the 1980s, when they brought about a breakthrough in the treatment of chronic diseases, especially cancer. They conquered a large space in the pipel
Externí odkaz:
https://doaj.org/article/b2bc4bddab7e4e79826c6ebd677fbf06
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5405-5414 (2021)
Cancer Medicine
Cancer Medicine
Background It has been suggested that the results from fragile trials are less likely to translate into benefit in routine clinical practice. Methods We searched the Food and Drug Administration (FDA) archives to identify drug approvals for solid org
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680358d1267743c6403e12774316a863
https://doaj.org/article/2af1bdd1e81e43c287847d8356afe589
https://doaj.org/article/2af1bdd1e81e43c287847d8356afe589
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Urothelial carcinoma therapy is a rapidly evolving and expanding field. Traditional cytotoxic chemotherapy regimens have not produced optimal long-term outcomes, and many urothelial cancer patients have comorbidities that disqualify them as chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::365224f3bdcafccd370e206863d590a5
https://doi.org/10.3389/fonc.2021.705294
https://doi.org/10.3389/fonc.2021.705294
Publikováno v:
Blood research
Despite expanding knowledge in the molecular landscape of acute myeloid leukemia (AML) and an increasing understanding of leukemogenic pathways, little has changed in the treatment of AML in the last 40 years. Since introduction in the 1970s, combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f40d3723c7db40386879dbd132d628a
http://europepmc.org/articles/PMC7386889
http://europepmc.org/articles/PMC7386889
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background It has been suggested that the results from fragile trials are less likely to translate into benefit in routine clinical practice. Methods We searched the Food and Drug Administration (FDA) archives to identify drug approvals for solid org
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::76f5bb2f93533f6125d2cf530dcf9b8b
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4487
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4487
